SEQIRUS UK LIMITED
Location
Founded
2015-05-29
Website
Risk Signals
39 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Offices of Holding Companies, Not Elsewhere Classified, Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SEQIRUS UK LIMITED
Live alerts from global media, monitored by Business Radar
2023-09-26 (fiercepharma.com)
UK puts CSL Seqirus on standby for flu pandemic preparedness, with vaccines to be produced in Liverpool
The last flu pandemic came and went in 2009—with lots of advanced hype and much less effect. When the next flu pandemic arrives and its severity is anyone’s guess. Either way, the U.K.| The U.K. has inked a four-year deal for CSL Seqirus to develop and manufacture more than 100 million
Read more
2023-09-05 (pharmiweb.com)
Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization A
EMA application supported by Phase 3 primary vaccination study demonstrating primary efficacy endpoint was metAn additional Phase 3 booster study demonstrating non-inferiority of immune response compared to Comirnaty® and superiority of ARCT-154 in neutralizing antibody response against SARS-CoV-...
Read more